Literaturverzeichnis

1 Adenis, A.; Conroy,T.; Lasser,P.; Merrouche,Y.; Monges , G.: Carcinoma of the colon; British Journal of Cancer; 2001, 84, Suppl.2, S. 65- 68

2 Aitken, R.A: Growing Edge of Measurements of Feelings; Proc. roy. Soc. Med.; 1969, 62, S. 989-996

3 Andreyev, H.J.N.: Why do Patients with Weight Loss have a Worse Outcome when Undergoing Chemotherpy for Gastrointestinal Malignancies?; l Eur J Canc; 1998, Vol. 34, No.4,S. 503-509

4 Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland: Krebs in Deutschland, Häufigkeiten und Trends; Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland, R.-Koch- Institut; 3. Auflage, Saarbrücken 2002

5 Ballmer, P.: Causes and Mechanisms of Hypoalbuminaemia; Clinical Nutrition; 2001, 20 (3), S.271-273

6 Banks, W. : Anorectic Effects of Circulating Cytokines: Role of the Vascular Blood-Brain Barrier; Nutrition; 2001, 17,S. 434-437

7 Baracos, V.: Hypercatabolism and Hypermetabolism in Wasting States; Current Opinion in clinical nutrition and metabolic care; 2002, 5,S. 237-239

8 Barber, M.D.; Ross, J.;Fearon, K.: Disordered Metabolic Response with Cancer and its Management; World Journal of Surgery; 2000, 24,S. 681-689

9 Baumann, H.; Gauldie, J.: The Acute Phase Response; Immunology Today; Vol.15, 1994, S. 74-80

10 Bernhard, J.; Maibach, R.; Thürlimann, B., Sessa, C.; Aapro, M.: Patients' Estimation of Overall Treatment Burden: Why Not Ask the Obvious?; Journal of Clinical Oncology; 2002, 20, S. 65- 72

11 Bernhard, J.; Sullivan, M.;Coates, A.; Rudenstam,C.: Clinical relevance of single item quality of life indicators in cancer clinical trials; British Journal of Cancer; 2001, 84 (9), S.1156-1165

12 Berthold, H.: Arzneimitteltherapie; 1. Auflage; Jena, Gustav Fischer Verlag, 1999

13 Berthoud, H.; Seeley, R.: An overview of neural pathways and networks involved in the control of food intake and selektion; Neuroscience Biobehaviour Review; 1999, 24, S. 361-387

14 Birch, L.: Developement of Food Preferences; Annual Review of Nutrition; 1999, 19, S. 41-62

15 Bley, T.; Rastall, R.: Altered Taste in Patients with Jaundice; Clinical Nutrition; 2003, 22, S. 58-59

16 Bossola,M.; Muscaritoli,M.; Bellatone,R.;Pacelli,F.; Cascino,A.; Sgadari,A.: Serum Tumor Necrosis Factor alpha Lvels in Cancer Patients are discontinuous and correlate with Weight Loss; European Journal of Clinical Investigation ; Vol.30, 2000, S. 1107-1112

17 Boyle, P.; Langman, J.: ABC of colorectal cancer; British Journal of Medicine; 2000, 321, S. 805-808

18 Brenna,F.B.: Uncomplicated starvation versus cancer cachexia; Cancer Research; 37, 1977, S. 7-12

19 Bruning, P.; Egger, R.; Gooskens, A.; Odink, J, Kistemaker, C.: Dietary Intake, Nutritional Status and Well-being of Cancer Patients: a Prospective Study; European Journal of Cancer and Clinical Oncology, 1985, 21, S. 1449-1459

20 Cahlin, Ch.; Körner, A.; Axelson, H.; Wang, W.; Lundholm, K.: Experimental Cancer Cachexia: The Role of Host-derived Cytokines Interleukin IL-6, Il-12, Interferon gamma and Tumor Necrosis Factor alpha Evaluated in Gene KNockout, Tumor-bearing Mice on C57 BI Background and Eicosanoid-dependent Cachexia, Cancer Research, Vol.60, 2000, S. 5488-5493

21 Coates, A.; Fischer Dillenbeck, C.; McNeil, D.: On the Receiving End- II. Linear Analogue Selfassessment (LASA) in Evaluation of Aspects of the Quality of Life of Cancer Patients Receiving Therapy; Eur J Cancer Clin Oncol, 1983, 19., Nov., S. 1633-1637

22 Copeland, K.: Acute growth hormone effects on amino acid and lipid metabolism; J Clin Endocrinol Metab; 1994, 78, S.1040-1047

23 Crown,A.; Cottle, K.; Lightman, S.; Falk, S.: What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?; Clinical Endocrinology; 2002, 56, S.723-733

24 deBraud, F.; Cascinu, S.; Gatta, G.: Cancer of pancreas; Clinical Reviews in Oncology/Hematology; 2004, 50, S.147-155

25 DeWys, WD.: Prognostic effect of weight loss prior to chemotherapy in cancer patients; American Journal of Medicine; 1980, 69, S.491-497

26 Dietrich, Ch.: Therapie des Hepatozellulären Karzinoms; Dt. Aerztebl; 2003, 12, S. A772- 782

27 Drewnowski, A.: Taste Preferences and Food Intake; Annual Review of Nutrition; 1997, 17, S. 237-253

28 Drewnowski, A.; Ahlstrom Henderson, S.; Barrat-Fornell, A.: Genetic taste markers and food preferences; Drug Metabolism and Dispostion; 2001, 29, S. 535-538

29 Drewnowski, A.; Hann, C.: Food preferences and reported frequencies of food consumption as predictors of current diet in young women ; American Journal of Clinical Nutrition, 1999, 70, S. 28-36

30 Dworzak,F.; Ferrari, P.; Gavazzi, C.; Maiorana, C.: Effects of Cachexia Due to Cancer on Whole Body and Skeletal Muscle Protein Turn Over; Cancer; Vol.82, 1998, S.42-48

31 Edington,J.: Prevalence of Malnutrition on admission to four hospitals in England; Clinical Nutrition; 2000, 19 (3), S.191- 195

32 Ehab, H.; Alexiou,M.; Morgan, J.; Penagaricano,J.; Fan, C.:Intensive Chemoradiotherapy as a Primary Treatment for Organ Preservation in Patients with Advenced Cancer of the Head and Neck; Arch Otolaryngol Head Neck Surg; 2004, 130, S. 861-868

33 Eickhoff, A.; Jakobs, R.; Riemann, J.: Ösophagus- und Magenkarzinom; Der Internist; 2004, 45, S. 756-768

34 Fanelli, F.: Cancer anorexia: a model for the understanding and treatment of secondary anorexia ; International Jounal of Cardiology; 2002, 85, S.67- 72

35 Fearon, K.; Barber,M.; Falconer, J.; McMillian, D.; Ross, J.; Preston,T.: Pancreatic Cancer as a Model: Inflammatory Mediators, Acute Phase Response and Cancer Cachexia; World Journal of Surgery, 1999, 23, S.584-588

36 Fearon, K.; Moses, A.: Cancer cachexia; International Journal of Cardiology, 2002, 85, S.73- 81

37 Forbes, St.; Bui, St.; Robinson,B.; Hochgeschwender, U.; Brennan,M.: Integrated control of appetit and fat metabolism by the leptin-proopiomelanocortin pathway PNAS; Physiology; 2001, 98 (7), S. 4233-4237

38 Fordy,C.; Glover, C.; Henderson, D.C.; Summerbell, C.: Contribution of Diet, Tumor Volume and Patient-Related Factors to Weight Loss in Patients with Colorectal Liver Metastases; British Journal of Surgery; 1998, 5, S. 639-644

39 Forro, M.; Cieslar, S.; Ecker, G.; Walzak, D.: Total body water and ECFV measured using bioelectrical impedance analysis and indicator dilution in horses; Journal of Applied Physiology; 2000, 89/2, S. 663-671

40 Foster, K.: Whole Body Impedance- what does it measure?; Am J CLin Nutr; 1996, 64 , S. 388S- 396S

41 Franch-Arcas, G.: The meaning of hypoalbuminaemia in clinical practice; Clinical Nutrition; 2001, 20 (3), S. 265-269

42 Frisancho, A.: Triceps skin fold and upper arm muscle size norms for assessment of nutritional status; American Journal of Clinical Nutrition; 1974, 27, S.1052-1058

43 Frisancho, A.: New norms of upper limb fat and muscle areas for assessment of nutritional status; American Journal of Clinical Nutrition; 1981, 34, S. 2540-2545

44 Fuchs, E.: Diagnostik und Therapie gastrointestinaler Tumoren; Onkologie Eschweiler; Nora Verlag GmbH, Stolberg, 2002

45 Galvan, O.; Sprinzl, G.; Hackl, J.; Gunkel, A.: Stellenwert eines Ernährungsscores bei Patienten mit fortgeschrittenen Karzinomen im Kopf-Hals-Bereich; HNO; 2000, 48, S. 928-936

46 Gelin, J.: The metabolic response to cancer; Proc Nutr Soc; 1992, 51, S. 279-284

47 Giovanni, M.;Elias, D.; Raoul, JL.; Rougier, P.: Hepatocellular Carcinoma; British Journal of Cancer; 2001, 84 Suppl. 2, S. 74- 77

48 Gough, I.; Furnival, C.; Schilder, L.: Assessment of the Quality of Life of Patients with Advanced Cancer; Eur J Cancer Clin Oncol; 1983, 19 (Aug), S.1161-1165

49 Hahn J.-M.: Innere Medizin; Stuttgart, Georg Thieme Verlag; 1997, 3. Auflage, "

50 Hall, J.C.: Altered taste thresholds in gastrointestinal cancer; Clinical Oncology; 1980, 6, S. 137-142

51 Hanna, E.; Alexiou, M.; Morgan, J.;Badley, J.: Intensive Chemoradiotherapy as a Primary Treatment for Organ Preservation in Patients with Advanced Cancer of the Head and Neck; Arch Otolaryngol Head Neck Surg; 2004 , 130 , S. 861-867

52 Harrison, G.: Harrisons Innere Medizin; M. Dietel, J. Dudenhausen, N. Suttorp; 15. Auflage, Berlin, ABW Wissenschaftsverlag, 2001

53 Heber, D.; Tchekmedyian, N.: Pathophysiology of cancer: hormonal and metabolic abnormalities; Oncology ; 49 Suppl2, 1992, S. 28-31

54 Heymsfield, S.; McManus, C.; Stevens, V.; Smith, J.: Muscle mass:reliable indicator of protein-energy malnutrition severity and outcome ; American Journal of Clinical Nutrition; 35, 1982, S. 1192-1199

55 Heymsfield, S.; ZiMian, W.: Human Body Composition: Advances in Models and Methods; Annual Reviews Nutrition;17, 1997, S. 527-558

56 Heymsfield, St.: Techniques used in the measurement of body composition:an overview with emphasis on bioelectrical impedance analysis; American Journal of Clinical Nutrition; 64 Suppl, 1996, S. 478S-484S

57 Heymsfield, St.: Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area; American Journal of Clinical Nutrition; 1982, 36, S. 680-690

58 Hirsch, J.: The interactions of nutrition and behavior; American Journal of Nutrition; 1982, 35, S. 1200-1201

59 Holm, E: Substrate Balances across Colonic Carcinoma in Humans; Cancer Research; 55, 1995, S. 1373-1378

60 Hulgji, A., Geisbers, A.; Poelhuis, E.; Hart, A.: Alterations in taste appreciation in cancer patients during treatment; Cancer Nursing; 1986, 9, S. 38-42

61 Inui, A.: Cancer anorexia-cachexia syndrome- are neuropeptides the key?; Cancer Research; 1999, 59, S. 4493- 4501

62 Ipsen, B.; Kondrup, J.: Weight maintenance in cancer patients during chemo- or radiotherapy; Journal of Clinical Nutrition; 2003, 22, S.64 -66

63 Isenring, E.; Capra, S.; Bauer, J.: Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area; British Journal of Cancer; 2004, 91, S. 447-452

64 Ito, H.; Miki, C.: Profile of circulating levels of lnterleukin-1 Receptor Antagonist and Interleukin-6 in colorectal cancer patients ; Scandinavian Journal of Gastroenterology; 1999, 11, S.1139-1140

65 Johnson, F.; Grace, M.: Alterations in taste sensation: a case presentation of a patient with endstage pancreatic cancer; Cancer Nursing; 2001, 24 , S.149-155

66 Katschinski, M.: Regulation von Appetit und Sättigung; Aktuelle Ernährungsmedizin; 2002, 27, S. 375-380

67 Khan, S.; Tisdale, M.: Catabolism of Adipose Tissue by a Tumor-Produced Lipid-Mobilising Factor; International Journal of Cancer; 1999, 80, S. 444-447

68 Koch, J.: The role of body composition measurements in wasting syndromes; Seminars in Oncology; 25 Suppl.6, 1998, S. 800 -810

69 Koolman, J. , Röhm, K.: Taschenatlas der Biochemie; Stuttgart, Georg Thieme Verlag, 3. Auflage, "

70 Kotler, DP.: Magnitude of body cell mass depletion and the timing of death from wasting in aids; Am J Clin Nutr; 1989, 50, S. 444-447

71 Kreibich Fischer, R.: Psychological Aspects of Malnutrition; Recent Results in Cancer Research;121, 1991, S. 296-300

72 Langhans, W.: Zentrale Regulation der Nahrungsaufnahme; Aktuelle Ernährungsmedizin; 2002, 27, S. 381-388

73 Langhans, W.; Hrupka, B.: Interleukins and tumor necrosis factor as inhibitors of food intake; Neuropeptides; 1999, 35/5, S. 415-424

74 Lazarus,D.; Destree, A.; Mazzola, L.; McCornack,T.; Dick, L.; BiXu, J.; Pierce, J .: A New Model of Cancer Cachexia: Contribution of the Ubiquitin- Proteasome Pathway; American Journal of Physiology- Endocrinology and Metabolism; Vol.27, 1999, S. E332-E341

75 Llovera, M.; Garcia-Martinez, C.; López-Soriano, J.; Carbó, N.; Agell, N.: Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knock out mice; Molecular and Cellular Endocrinology, 1998, 142, S. 183-189

76 Llovet, J.; Bruix, J.: Early diagnosis and treatment of hepatocellular carcinoma; Clinical Gastroentology; 2000, 6, S. 991-1008

77 Lukaski, H.: Biological indexes considered in the derivation of the bioelectrical impedance analysis; Am J Clin Nutr; 1996, 64, S. 397S-404S

78 Mackiewicz, A.: Acute Phase Response; Molecular Biology, Biochemistry and Clinical Applications; CRC Press; 1993, 1, S. 686 -691

79 Mantovani, G.; Maccio, A.; Mura, L.; Mudu, M.; Madeduddu, C.: Serum Levels of Leptin and Proinflammatory Cytokines in Patients with advanced-stage Cancer at different Sites; Journal of Molecular Medicine; 2000 , 78 (10),S. 554-561

80 Martin, F.; Santolaria, F.; Batista, N.; Milena, A.: Cytokins Levels (IL-6 and IFN-gamma), Acute Phase Response and Nutritional Status as Prognostic Factors in Lung Cancer; Cytokine; Vol.11, 1999, S. 80-86

81 Mattes, R.: Clinical Implications of Learned Food Aversions in Patients with Cancer Treated with Chemotherapy or Radiation; Therapy Cancer; 1999, 21, S. 192-200

82 National Institutes of Health Technology: Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology assessment conference statement; American Journal of Clinical Nutrition; 1996, 64(Suppl), S. 524S- 532S

83 Nelson, K.: The Cancer-Anorexia-Cachexia Syndrome; Seminars in Oncology; 27, 2000, S. 64-6 9

84 Neumeiser, B.: Klinikleitfaden Labordiagnostik; 2. Auflage, München und Jena; Urban und Fischer Verlag, 2000

85 Ng, K.; Woo, J.; Kwan, M.; Lo, R.; Chan, A.: Effect of Age and Disease on Taste Perception; Journal of Pain and Symptom Management; 2004, 28.,S. 28-34

86 Nielsen, S.; Athanasios, T.; Vickers, Z.: Influence of food odors on food aversions and preferences in patients with cancer; American Journal of Clinical Nutrition; 1980, 33, S. 2253-2261

87 Ollenschläger, G.; Schrappe- Bächer, B.; Steffen, M.; Bürger, B.; Allolio, B.: Erhebung des Ernährungszustandes in der klinischen Routinediagnostik: Cholinesterase- Aktivität als Ernährungsindikator ; Klinische Wochenschrift; 1989, 67, S.1101- 1107

88 Ollenschläger, G.; Thomas, W.; Konkol, K.;Diehl, V.; Roth, E.: Nutritional behaviour and quality of life during oncological polychemotherapy: Results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia ; European Journal of Clinical Investigation; 1992, 22, S. 546-553

89 Ollenschläger, O.: Zur Pathogenese und Therapie der Malnutrition in der Onkologie; Zeitschrift für Ernährungswissenschaft; 1982, 21, S.124-145

90 Opera, E.: Correlation between food intake and CSF IL- 1 in anorectic tumor bearing rats; NeuroReport; 1995, 6, S. 750- 752

91 Ortner, M.: Photodynamic therapy for cholangiocarcinoma; J-Hepatobiliary-Pancreat-Surg.; 2001, 8, S. 137-139

92 Ott, M .: Early changes of body composition in human immunodeficiency virus infectd patients: Tetrapolar body impedance analysis indicates significant malnutrition; Am J Clin Nutr; 1993, 57, S. 15-19

93 Pirlich, M.; Plauth, M.; Lochs, H.: Bioelektrische Impedanzanalyse: Fehlerquellen und methodische Grenzen bei der klinischen Anwendung zur Analyse der Körperzusammensetzung ; Akt.Ernähr.-Med.; 1999, 24, S. 81-90

94 Pirlich, M.; Schütz, T.; Kemps, M.; Luhmann, N.;Plauth, M.;Lübke, H.; Lochs, H.: Prevalence of Malnutrition in Hospitalized Medical Patients: Impact of Underlying Disease; Digestive Disease; 2003, 21, S. 245-251

95 Pirlich, M.; Schwenk, A.; Müller, M.; Ockenga, J.; Schütz, T.; Selberg, O.: DGEM-Leitlinie Enterale Ernährung: Ernährungsstatus; Aktuelle Ernährungsmedizin; 2003, 28, S. S10-S25

96 Preiß, K.: Onkologie 2000; Onkologische Arbeitsgemeinschaft Saar-Pfalz-Mosel e. V.; 10. Auflage W. Zuckschwerdt Verlag, 2000, "

97 Pschyrembel: Klinisches Wörterbuch; H. Hildebrandt ; 257. Auflage , Berlin, Walter de Gruyter, 1995, "

98 Puccio,M.; Nathanson,L.: The Cancer Cachexia Syndrome; Seminars in Oncology; Vol.24, 1997,S. 277-287

99 Raben, A.; Tagliabue,A.;Astrup, A.: The reproducibility of subjective appetite scores; British Journal of Nutrition; 1995, 73, S. 517-530

100 Ravasco, P.; Grillo, I.; Marques Vidal, P.; Camilo, M.: Nutrition and Patient Outcome: a prospective randomised controlled trial in colorectal cancer patients undergoing radiotherapy; Journal of Clinical Nutrition; 2003, 22, S. S63

101 Roubenoff, R.: Standardization of nomenclature of body composition in weight loss; American Journal of Clinical Nutrition; 1997, 66, S.192-196

102 Schindler, K.;Sunder-Plassmann, G.: Protein-Energie- Malnutrition und Organdysfunktion; Aktuelle Ernährungsmedizin; 2001, 26, S. 56-61

103 Schlag,P.; Decker-Baumann,C.: Strategies and needs for nutritional support in cancer surgery; Recent Results in Cancer Research; 121, 1991, S. 45-52

104 Schwenk, A.; Beisenherz, A.; Römer, K.;Kremer, G.; Elia, M.: Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment; American Journal of Clinical Nutrition; 2000, 72/2, S. 496-501

105 Seitz,J.; Sarradet, A.; Francois, E.; Jacob,J.; Rougier, P.; Roussel, A.: Carcinoma of the Oesophagus; British Journal of Cancer; 2001, 84 Suppl.2, S. 61- 64

106 Selberg, O.: Ursachen und Charakteristika der Tumorkachexie-Perspektiven einer ernährungsmedizinischen Behandlung; Ernährungsumschau; 47, 2000, S. 298-303

107 Seppelt, B.; Zunft, H.: Sensitivität und Präferenz zum Süßgeschmack unter langfristig verändertem Kohlenhydratverzehr; Ernährungsumschau, 2000, 1, S. 385-399

108 Sharma, R.; Anker, S.: Cytokines, apoptosis and cachexia: the potential for TNF antagonism; International Journal of Cardiology; 2002, 85, S.161-171

109 Smith, B.K.: Anti TNF-alpha antibodies normalised body temperature and enhanced food intake in tumor bearing rats; Am J Physiol; 1993, 265, S. R615 -622

110 Spangenberg, H.; Thimme, R.; v.Weizsäcker,F.; Blum, E.: Hepatozelluläres Carzinom; Der Internist; 2004, 45, S. 777-785

111 Strassmann, G.: Evidence for the involvement of IL-6 in experimental cancer cachexia; J Clin Invest;1992,89, S. 1681 -1689

112 Tisdale, M.: Protein Loss in Cancer Cachexia; Science; Vol.289, 2000, S. 2293-2295

113 Tisdale, M.: Cancer Anorexia and Cachexia; Nutrition; 2001, 17, S.438-442

114 Tisdale, M.: Wasting in Cancer; Journal of Nutrition; 1999, 1, S. 243S-246S

115 Trant, A.: Is taste related to anorexia in cancer patients?; American Journal of Clinical Nutrition; 1982, 36 (7), S. 45-58

116 Volk, H.D.: Skript Einführung in theoretische Grundlagen der Immunologie; Berlin 1998; S.17

117 Wang,W.; Iresjö,B.; Karlsson,L.; Svanberg,E.: Provision of rhIGF-I/ IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model; Clinical Nutrition, 2000, 2, S.127-132

118 Wickham, R.; Rehwaldt, M.; Kefer, C.: Taste changes experienced by patients receiving chemotherapy; Oncology Nurse Forum; 1999, 26, S. 697-706

119 Wils, J.; O'Dwyer, P.; Labianca, R.: Treatment of colorectal cancer at the turn of the century: European and US perspectives ; Annals of Oncology; 2001, 12, S. 13-20

120 Wolff/ Weihrauch: Internistische Therapie 2000/ 2001; Urban & Fischer Verlag; 13. Auflage, München/ Jena, Urban & Fischer Verlag, 2000

121 Yackinous, C.; Guinard, J.: Relation between PROP (6-n-propylthiouracil) taster status, taste anatomy and dietary intake measures for young man and women; Appetite; 2002, 38, S. 201-209